AMY MILLER: Open Payments
NPI 1851900385 · WALKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 21 payments from 9 companies in 2025. Trend: 2023 $862 · 2024 $485 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 5 | $171 |
| Boston Scientific Corporation | 2 | $137 |
| Collegium Pharmaceutical, Inc. | 6 | $122 |
| Averitas Pharma Inc. | 3 | $71 |
| Medtronic, Inc. | 1 | $50 |
| MERZ NORTH AMERICA, INC. | 1 | $43 |
| Bioventus LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: Evoke, Intracept, Belbuca, QUTENZA, SYNCHROMEDII, Xeomin, DUROLANE, RELISTOR.
Industry payments across LA — which companies pay providers there.
